Characteristic | Total | Rebleeding | Non-rebleeding | P |
---|---|---|---|---|
N = 386 | N = 48 | N = 338 | ||
Age, median (IQR) | 56 (43–65) | 54 (31.5–65) | 56 (43–65) | 0.229 |
Sex: male [No. (%)] | 313 (81.1) | 37 (77.1) | 276 (81.7) | 0.555 |
Alcohol use [No. (%)] | 64 (16.6) | 5 (10.4) | 59 (17.5) | 0.299 |
Smokers [No. (%)] | 119 (30.8) | 9 (18.8) | 110 (32.5) | 0.077 |
Haematemesis [No. (%)] | 194 (50.3) | 40 (83.3) | 154 (45.6) | 0.001 |
Medication history | ||||
 Use of NSAIDs [No. (%)] | 22 (5.7) | 2 (4.2) | 20 (5.9) | 0.875 |
 Use of anticoagulants [No. (%)] | 4 (1) | 0 | 4 (1.2) | 1 |
PU bleeding history [No. (%)] | 73 (18.9) | 5 (10.4) | 68 (20.1) | 0.108 |
Coexisting diseases [No. (%)] | ||||
 Hypertension | 90 (23.3) | 10 (20.8) | 80 (23.7) | 0.664 |
 Diabetes mellitus | 34 (8.8) | 3 (6.3) | 31 (9.2) | 0.692 |
Shock [No. (%)] | 53 (13.7) | 23 (47.9) | 30 (8.9) | < 0.001 |
Systolic blood pressure [mmHg, median (IQR)] | 114 (103–128) | 110 (96–131.5) | 114 (104–127) | 0.484 |
Diastolic blood pressure (mmHg, mean ± SD) | 70.14 ± 0.68 | 68.88 ± 2.37 | 70.32 ± 0.70 | 0.560 |
Heart rate [beats/min, median (IQR)] | 86 (73–99) | 99 (80.5–109.5) | 85 (73–97) | < 0.001 |
Surgery due to rebleeding [No. (%)] | 15 (3.9) | 15 (31.1) | 0 | < 0.001 |
Mortality [No. (%)] | 16 (4.1) | 16 (33.3) | 0 | < 0.001 |
Blood transfusion [No. (%)] | 192 (49.7) | 33 (68.8) | 159 (47) | 0.005 |
Hospitalization stay, median (IQR) | 7 (5–10) | 12 (7–20) | 6 (5–9) | < 0.001 |
Glasgow-Blatchford score, median (IQR) | 10 (8–12) | 10 (8–13) | 10 (8–12) | 0.138 |
Rockall score, median (IQR) | 4 (3–4) | 4 (3–5) | 4 (3–4) | 0.074 |
AIMS65 score, median (IQR) | 1 (0–1) | 2 (1–3) | 0 (− 1) | < 0.001 |